D-serine suppresses one-carbon metabolism by competing with mitochondrial L-serine transport

Inside the cells of our bodies, a vast network of chemical reactions keeps life running. Among the most vital of these is a process called one-carbon metabolism. Think of this as a cellular assembly line that takes a specific building block, an amino acid called L-serine, and breaks it down to release single carbon units. These tiny units are then used to construct the DNA that carries our genetic code, to build the fats that make up our cell membranes, and to create the chemical signals our nerves use to talk to one another. Without this assembly line, cells cannot divide, grow, or function properly. In the developing brain, this process is especially critical, as the rapid creation of new nerve cells demands a constant supply of these building blocks. For decades, scientists have known that L-serine is the fuel for this engine, but a mystery remained regarding its mirror image, D-serine. While L-serine is the standard form used by the body, D-serine is also produced in the brain, where it is famous for acting as a chemical messenger that helps neurons communicate. However, its role inside the cell's metabolism was unclear, leaving researchers to wonder if this mirror-image molecule was merely a passenger or an active participant in the cell's chemistry.

A team of researchers set out to solve this puzzle by watching how D-serine behaves when it enters a cell. They began by observing brain cells in a dish, adding either L-serine or D-serine and measuring the chemical changes that followed. They found that while L-serine boosted the activity of the one-carbon assembly line, D-serine did the opposite. When D-serine was present, the levels of key products dropped sharply, including glycine, a molecule essential for nerve function, and formate, a crucial intermediate in the metabolic pathway. This suggested that D-serine was not just inactive, but was actively suppressing the very process that L-serine was meant to drive. The researchers then asked how this happened. One possibility was that D-serine was clogging the machinery of the enzyme responsible for the first step of this process, a protein called serine hydroxymethyltransferase 2, which sits inside the cell's powerhouses, the mitochondria. To test this, they used computer simulations to watch how the molecules interacted. The simulations showed that D-serine did not fit well into the enzyme's active site and could not stay there long enough to block it. Furthermore, when they tested the enzyme directly in a lab setting, D-serine had no effect on its ability to process L-serine. The enzyme worked just fine even when D-serine was present.

The answer lay not in the enzyme itself, but in how the molecules got to it. The researchers discovered that D-serine acts as a gatekeeper at the entrance to the mitochondria. To reach the enzyme, L-serine must be transported across the mitochondrial membrane through a specific doorway. The team found that D-serine competes for this same doorway. Because D-serine is a mirror image of L-serine, it can slip into the transport channel, but it cannot pass through to the other side. By occupying the channel, it blocks L-serine from entering the mitochondria. Without L-serine inside the mitochondria, the one-carbon assembly line grinds to a halt. The researchers confirmed this by measuring the transport of radioactive L-serine into mitochondria; when D-serine was added, the transport rate dropped significantly. This competition means that even if there is plenty of L-serine in the cell, the mitochondria are starved of it if D-serine levels are high.

This metabolic blockade has profound consequences for cell growth. The researchers tested this on various types of neural cells, including immature nerve cells and brain tumor cells, which rely heavily on the one-carbon pathway to multiply. In conditions where L-serine was scarce, adding D-serine stopped these cells from dividing and, in the case of immature nerve cells, triggered them to die. The death was not caused by the well-known excitotoxic effects of D-serine on nerve signaling, nor was it due to a failure in making fats for cell membranes. Instead, it was a direct result of the cell running out of the carbon units needed to build DNA. The researchers found that they could rescue the dying cells by adding back the specific products of the blocked pathway, such as glycine and formate, proving that the lack of these molecules was the true cause of the cell death.

The study also revealed a fascinating shift in how the brain handles these molecules as it matures. During early development, when the brain is building new circuits and cells are dividing rapidly, the levels of D-serine are extremely low, allowing the one-carbon assembly line to run at full speed. However, as the brain matures and cells stop dividing to focus on communication, the production of D-serine increases. The researchers traced this change to the activity of an enzyme called serine racemase, which converts L-serine into D-serine. This enzyme is barely active in immature cells but becomes highly active in mature neurons. This timing suggests that the brain naturally switches off its own growth engine by producing D-serine once the cells have finished dividing. In the mature brain, where cells are no longer trying to multiply, the presence of D-serine does not harm the cells because they do not depend on the one-carbon pathway for survival in the same way. Instead, D-serine takes on its role as a neurotransmitter, fine-tuning the signals between neurons.

These findings offer a new perspective on how the shape of a molecule can dictate the fate of a cell. The research shows that the brain uses the simple act of flipping a molecule from one shape to its mirror image to control a fundamental metabolic switch. By producing D-serine only after the brain has finished its rapid growth phase, nature ensures that the metabolic machinery required for cell division is turned off, preventing unnecessary proliferation while allowing the mature brain to focus on its primary job of thinking and feeling. This discovery also sheds light on certain brain tumors, which often retain the ability to divide and are highly sensitive to this metabolic blockade. The study suggests that the competition between these two forms of serine is a powerful, naturally occurring regulator of cell growth, one that the brain has evolved to manage with precision.